Effectiveness of a Needle-free Connector With Anti-reflux Technology in Reducing Complications From Long Peripheral Venous Catheters in Hospitalised Adult Patients: Randomised Clinical Trial
Needle-free connector with neutral fluid displacement and without anti-reflux technologyNeedle-free connector with neutral fluid displacement and equipped with anti-reflux technologyLong peripheral venous catheterUltrasound scanner
Needle-free connector with neutral fluid displacement and without anti-reflux technology: Placement of a needle-free connector with neutral fluid displacement and no anti-reflux technology onto a long PVC.
Needle-free connector with neutral fluid displacement and equipped with anti-reflux technology: Placement of a needle-free connector featuring neutral fluid displacement and anti-reflux technology onto a long PVC.
Long peripheral venous catheter: Placement of a 20-gauge long PVC in an arm vein using the AST.
Ultrasound scanner: All punctures will be performed under ultrasound guidance.
Study summary
A study to evaluate a needle-free connector (a stopper) featuring anti-reflux technology (to prevent blood from flowing back) for catheters (polyurethane tubes inserted into a vein), with the aim of reducing complications associated with these devices: blockages, infections, pain, etc.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients requiring placement of a long peripheral venous catheter.
* Patients who have provided written informed consent.
* Patients with an expected hospital stay of ≥7 days.
Exclusion Criteria:
\- Inability to place a long peripheral venous catheter in the upper limbs.
Primary outcome measure(s)
Number of participants who experienced device-related adverse events, classified according to CTCAE v5.0. — 7 days Percentage of participants experiencing adverse events following insertion of a long peripheral venous catheter and placement of a needle-free connector featuring neutral fluid displacement and anti-reflux technology (Clave™ Neutron™, Ref. 011-NC139).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.